Found 22 matching trials
Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer? N/A The recurrent pancreatic cancer (Rec-PC) after radical surgery is sometimes...
Show More Location
Multiple Locations
Learn More & Join Trial
Metastasis-directed Therapy for Oligometastases of Breast Cancer PHASE3 OLIGAMI trial is a multi-institutional, two-arm, open-label, randomized con...
Show More Location
Tokyo Medical and Dental Univetsity
Learn More & Join Trial
Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas PHASE2 A randomized multi-center phase II trial of nab-paclitaxel in combination w...
Show More Location
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma N/A The purpose of this study is to compare chemotherapy plus immunotherapy wit...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients PHASE2 Pancreatic cancer is one of the deadliest tumor types, there is no effectiv...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Personalized Precision Diagnosis and Treatment of Pancreatic Cancer NA Pancreatic cancer (PC) is the 4th common cancer in the world and occupied t...
Show More Location
Changhai Hospital
Learn More & Join Trial
Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer PHASE2 This is a randomized phase II trial comparing the first-line treatment with...
Show More Location
Peking University Cancer Hospital and Institute
Learn More & Join Trial
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract PHASE2 Gemcitabine plus cisplatin have been the most studied and used anticancer a...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma PHASE1 A Phase 1b, open-label, multicenter, dose escalation and dose expansion stu...
Show More Location
Chiayi Chung Gung Memmorial Hospital
Learn More & Join Trial
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen PHASE2 This is a single arm, open label Phase II clinical trial to evaluate the ef...
Show More Learn More & Join Trial